Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1322871 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of MAGI1 mRNA | CTD | PMID:22079256 | 1,2-dichloroethane | increases expression | EXP | | 6480464 | ethylene dichloride results in increased expression of MAGI1 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of MAGI1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | RGD:1586025 | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of MAGI1 mRNA | CTD | PMID:26496021 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1586025 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAGI1 mRNA | CTD | PMID:32109520 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of MAGI1 mRNA | CTD | PMID:20188158 | 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of MAGI1 mRNA | CTD | PMID:23519560 | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of MAGI1 mRNA | CTD | PMID:18648102 | 7,12-dimethyltetraphene | decreases expression | EXP | | 6480464 | 9 more ... | CTD | PMID:32553695 | aflatoxin B1 | increases methylation | ISO | RGD:1322871 | 6480464 | Aflatoxin B1 results in increased methylation of MAGI1 gene, Aflatoxin B1 results in increased methylation of MAGI1 intron | CTD | PMID:27153756, PMID:30157460 | aflatoxin B2 | increases methylation | ISO | RGD:1322871 | 6480464 | aflatoxin B2 results in increased methylation of MAGI1 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | RGD:1322871 | 6480464 | Tretinoin results in decreased expression of MAGI1 mRNA | CTD | PMID:21934132 | arsane | affects methylation | ISO | RGD:1322871 | 6480464 | Arsenic affects the methylation of MAGI1 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RGD:1322871 | 6480464 | Arsenic affects the methylation of MAGI1 gene | CTD | PMID:25304211 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzoapyrene results in decreased expression of MAGI1 mRNA | CTD | PMID:19770486 more ... | benzo[a]pyrene | decreases expression | ISO | RGD:1322871 | 6480464 | Benzoapyrene results in decreased expression of MAGI1 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | ISO | RGD:1322871 | 6480464 | Benzoapyrene results in decreased methylation of MAGI1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | RGD:1322871 | 6480464 | Benzoapyrene results in increased methylation of MAGI1 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzoapyrene results in increased methylation of MAGI1 intron | CTD | PMID:27901495 | bisphenol A | multiple interactions | ISO | RGD:1586025 | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of MAGI1 mRNA | CTD | PMID:26496021 | bisphenol A | decreases methylation | ISO | RGD:1586025 | 6480464 | bisphenol A results in decreased methylation of MAGI1 gene | CTD | PMID:28505145 | bisphenol A | increases methylation | ISO | RGD:1586025 | 6480464 | bisphenol A results in increased methylation of MAGI1 gene | CTD | PMID:28505145 | bisphenol A | decreases expression | ISO | RGD:1586025 | 6480464 | bisphenol A results in decreased expression of MAGI1 mRNA | CTD | PMID:25181051, PMID:30816183 | butanal | decreases expression | ISO | RGD:1322871 | 6480464 | butyraldehyde results in decreased expression of MAGI1 mRNA | CTD | PMID:26079696 | cadmium atom | increases expression | ISO | RGD:1322871 | 6480464 | Cadmium results in increased expression of MAGI1 mRNA | CTD | PMID:21120746 | cadmium dichloride | decreases expression | ISO | RGD:1322871 | 6480464 | Cadmium Chloride results in decreased expression of MAGI1 mRNA | CTD | PMID:25851441 | calcitriol | decreases expression | ISO | RGD:1322871 | 6480464 | Calcitriol results in decreased expression of MAGI1 mRNA | CTD | PMID:16002434 | carbamazepine | affects expression | ISO | RGD:1322871 | 6480464 | Carbamazepine affects the expression of MAGI1 mRNA | CTD | PMID:24752500 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAGI1 gene | CTD | PMID:20938992 | cisplatin | multiple interactions | ISO | RGD:1322871 | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of MAGI1 mRNA | CTD | PMID:27392435 | cisplatin | decreases expression | ISO | RGD:1322871 | 6480464 | Cisplatin results in decreased expression of MAGI1 mRNA | CTD | PMID:27392435 | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of MAGI1 mRNA | CTD | PMID:23811191 | cobalt dichloride | decreases expression | ISO | RGD:1586025 | 6480464 | cobaltous chloride results in decreased expression of MAGI1 mRNA | CTD | PMID:24386269 | coumestrol | decreases expression | ISO | RGD:1322871 | 6480464 | Coumestrol results in decreased expression of MAGI1 mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | ISO | RGD:1322871 | 6480464 | [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in decreased expression of MAGI1 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases methylation | ISO | RGD:1322871 | 6480464 | Cyclosporine results in decreased methylation of MAGI1 promoter | CTD | PMID:27989131 | cytarabine | increases expression | ISO | RGD:1322871 | 6480464 | Cytarabine results in increased expression of MAGI1 mRNA | CTD | PMID:21198554 | diclofenac | affects expression | ISO | RGD:1322871 | 6480464 | Diclofenac affects the expression of MAGI1 mRNA | CTD | PMID:24752500 | dioxygen | increases expression | ISO | RGD:1322871 | 6480464 | Oxygen deficiency results in increased expression of MAGI1 mRNA | CTD | PMID:26516004 | doxorubicin | increases expression | ISO | RGD:1322871 | 6480464 | Doxorubicin results in increased expression of MAGI1 mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | ISO | RGD:1586025 | 6480464 | Endosulfan results in decreased expression of MAGI1 mRNA | CTD | PMID:29391264 | endosulfan | affects expression | ISO | RGD:1586025 | 6480464 | Endosulfan affects the expression of MAGI1 mRNA | CTD | PMID:31464424 | Enterolactone | multiple interactions | ISO | RGD:1322871 | 6480464 | [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in decreased expression of MAGI1 mRNA | CTD | PMID:19167446 | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of MAGI1 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAGI1 gene | CTD | PMID:20938992 | gemcitabine | increases expression | ISO | RGD:1322871 | 6480464 | gemcitabine results in increased expression of MAGI1 mRNA | CTD | PMID:17039268 | genistein | increases methylation | ISO | RGD:1586025 | 6480464 | Genistein results in increased methylation of MAGI1 gene | CTD | PMID:28505145 | hemin | multiple interactions | ISO | RGD:1322871 | 6480464 | [Hemin co-treated with MIR486-1 mRNA] affects the expression of MAGI1 mRNA more ... | CTD | PMID:32198055 | hydroquinone | multiple interactions | ISO | RGD:1322871 | 6480464 | [hydroquinone co-treated with Hemin] affects the expression of MAGI1 mRNA more ... | CTD | PMID:32198055 | irinotecan | decreases expression | ISO | RGD:1586025 | 6480464 | Irinotecan results in decreased expression of MAGI1 mRNA | CTD | PMID:20097248 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAGI1 gene | CTD | PMID:20938992 | lead(0) | affects splicing | ISO | RGD:1322871 | 6480464 | Lead affects the splicing of MAGI1 mRNA | CTD | PMID:28903495 | lead(2+) | affects splicing | ISO | RGD:1322871 | 6480464 | Lead affects the splicing of MAGI1 mRNA | CTD | PMID:28903495 | leflunomide | increases expression | ISO | RGD:1322871 | 6480464 | leflunomide results in increased expression of MAGI1 mRNA | CTD | PMID:28988120 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of MAGI1 mRNA | CTD | PMID:19751817 | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of MAGI1 mRNA | CTD | PMID:26307267 | methapyrilene | decreases expression | ISO | RGD:1586025 | 6480464 | Methapyrilene results in decreased expression of MAGI1 mRNA | CTD | PMID:30467583 | methylmercury chloride | increases expression | ISO | RGD:1322871 | 6480464 | methylmercuric chloride results in increased expression of MAGI1 mRNA | CTD | PMID:23179753, PMID:28001369 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of MAGI1 mRNA | CTD | PMID:22776087 | N-Nitrosopyrrolidine | decreases expression | ISO | RGD:1322871 | 6480464 | N-Nitrosopyrrolidine results in decreased expression of MAGI1 mRNA | CTD | PMID:32234424 | nickel atom | decreases expression | ISO | RGD:1322871 | 6480464 | Nickel results in decreased expression of MAGI1 mRNA | CTD | PMID:24768652, PMID:25583101 | nickel sulfate | decreases expression | ISO | RGD:1322871 | 6480464 | nickel sulfate results in decreased expression of MAGI1 mRNA | CTD | PMID:22714537 | O-methyleugenol | decreases expression | ISO | RGD:1322871 | 6480464 | methyleugenol results in decreased expression of MAGI1 mRNA | CTD | PMID:32234424 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of MAGI1 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | RGD:1322871 | 6480464 | Acetaminophen results in decreased expression of MAGI1 mRNA | CTD | PMID:21420995 | PCB138 | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of MAGI1 mRNA | CTD | PMID:23519560 | potassium chromate | decreases expression | ISO | RGD:1322871 | 6480464 | potassium chromateVI results in decreased expression of MAGI1 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | RGD:1322871 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of MAGI1 mRNA | CTD | PMID:22079256 | propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of MAGI1 mRNA | CTD | PMID:21278054 | silicon dioxide | decreases expression | ISO | RGD:1322871 | 6480464 | Silicon Dioxide analog results in decreased expression of MAGI1 mRNA | CTD | PMID:25895662 | sodium arsenate | increases expression | EXP | | 6480464 | sodium arsenate results in increased expression of MAGI1 mRNA | CTD | PMID:21795629 | sulindac sulfide | increases expression | ISO | RGD:1322871 | 6480464 | sulindac sulfide results in increased expression of MAGI1 mRNA | CTD | PMID:12734198 | trimellitic anhydride | decreases expression | EXP | | 6480464 | trimellitic anhydride results in decreased expression of MAGI1 mRNA | CTD | PMID:19042947 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of MAGI1 mRNA | CTD | PMID:28973697 | valproic acid | decreases methylation | ISO | RGD:1322871 | 6480464 | Valproic Acid results in decreased methylation of MAGI1 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | RGD:1322871 | 6480464 | Valproic Acid results in increased expression of MAGI1 mRNA | CTD | PMID:26272509 | vinclozolin | decreases expression | ISO | RGD:1586025 | 6480464 | vinclozolin results in decreased expression of MAGI1 mRNA | CTD | PMID:23034163 | zinc sulfate | increases expression | ISO | RGD:1322871 | 6480464 | Zinc Sulfate results in increased expression of MAGI1 mRNA | CTD | PMID:16330358 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| Save what matters to you |
| {{ loginError }} |
| Sign in with your RGD account |
| Create New Account | Recover Password |
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Phenotype Annotations Click to see Annotation Detail View
Mammalian Phenotype
Gene-Chemical Interaction Annotations
Click to see Annotation Detail View
Gene Ontology Annotations
Click to see Annotation Detail View
Cellular Component
|
|
|
Molecular Function
|
|
|
Phenotype Annotations
Click to see Annotation Detail View
Mammalian Phenotype
|
|
|
References
References - curated
| 1. | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
| 2. | RGD automated import pipeline for gene-chemical interactions |
Additional References at PubMed
| PMID:8889548 | PMID:9395497 | PMID:10349636 | PMID:10772923 | PMID:11042159 | PMID:11076861 | PMID:11077444 | PMID:11125038 | PMID:11217851 | PMID:11274227 | PMID:11350080 | PMID:12466851 |
| PMID:12477932 | PMID:12520002 | PMID:12773569 | PMID:12904583 | PMID:14610273 | PMID:15304526 | PMID:15317815 | PMID:15383320 | PMID:15509766 | PMID:15558322 | PMID:15908431 | PMID:16019084 |
| PMID:16043488 | PMID:16141072 | PMID:16141073 | PMID:17191119 | PMID:17938206 | PMID:17967808 | PMID:18799693 | PMID:18971469 | PMID:20219992 | PMID:20562105 | PMID:21267068 | PMID:21677750 |
| PMID:21873635 | PMID:23523645 | PMID:23769981 | PMID:24448406 | PMID:27707879 | PMID:28671696 | PMID:30944250 | PMID:32253237 | PMID:32325033 | PMID:32581705 |
Genomics
